by Truveta Research | Mar 30, 2023 | Research, Research Insights
We recently released insights exploring basketball- and soccer-related sports injuries, which inspired us to look into other sports. With over 15 million baseball players in the US and nearly 70 million people who attended a Major League Baseball (MLB) game in 2019,...
by Truveta Staff | Mar 23, 2023 | Technology
Chronic Kidney Disease (CKD) impacts more than 1 in 7 adults in the United States, totaling roughly 37 million people. March is National Kidney Disease Month – an important awareness initiative, as up to 90% of those with CKD are unaware of their condition....
by Truveta Staff | Mar 22, 2023 | News
Today, Truveta and Alpine Immune Sciences, Inc. announced a strategic partnership to help accelerate clinical trial recruitment for povetacicept, Alpine’s dual B cell cytokine antagonist being developed for multiple B cell-mediated autoimmune and inflammatory...
by Truveta Research | Mar 21, 2023 | Research, Research Insights
Today we continue our series of sports injury-related insights. Truveta Research first started looking at sports-related injuries following Damar Hamlin’s cardiac event during Monday Night Football on January 2, and after exploring in Truveta Studio, we shared that...
by Truveta Research | Mar 10, 2023 | Research, Research Insights
Today we kick off a series of sports injury-related insights. Truveta Research first started looking at sports-related injuries following Damar Hamlin’s cardiac event during Monday Night Football on January 2, and after exploring in Truveta Studio, we shared that...
